CHRISTIE SCHUMACHER: Open Payments
NPI 1306243779 · CLARKSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 30 payments from 9 companies in 2025. Trend: 2023 $1,042 · 2024 $725 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $298 |
| Janssen Pharmaceuticals, Inc | 5 | $75 |
| ABBVIE INC. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $36 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: COBENFY, INVEGA SUSTENNA, VRAYLAR, CAPLYTA, Auvelity, Xelstrym, REXULTI, UZEDY.
Industry payments across TN — which companies pay providers there.
